GLTO
Galecto Inc
NASDAQ: GLTO · HEALTHCARE · BIOTECHNOLOGY
$25.66
+7.23% today
Updated 2026-04-30
Market cap
$43.73M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-12.11
Dividend yield
—
52W range
$2 – $38
Volume
0.3M
Galecto Inc (GLTO) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Operating cash flow | $-13.69M | $-19.33M | $-38.20M | $-52.31M | $-42.93M | $-36.91M | $-18.62M |
| Capital expenditures | $223000.00 | $223000.00 | $223000.00 | $223000.00 | $196000.00 | $83000.00 | $0.00 |
| Depreciation | — | — | — | — | — | — | — |
| Stock-based comp | $81000.00 | $374000.00 | $982000.00 | $4.48M | $5.57M | $5.43M | $3.24M |
| Free cash flow | $-13.91M | $-19.55M | $-38.43M | $-52.53M | $-43.13M | $-36.99M | $-18.62M |
| Investing cash flow | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | $-30.04M | — | — |